In the TCGA cohort, expression of PTEN, a negative regulator of the integrin-FAK signaling, appeared downregulated or mutated in a large portion of KRAS mutated NSCLC patient biopsies, compared to their counterpart (Figure 6B). This evidence concerns the gene KRAS and non-small cell lung carcinoma.